Search Results

Nucleus-targeted Silencer nanoplatform regulating ZEB1-AS1 in head and neck squamous cell carcinoma therapy.

• Authors : Yang, Haojie; Zhang, Yangfan; Tan, Zicong

Subjects: SQUAMOUS cell carcinoma; EPITHELIAL-mesenchymal transition; GENETIC translation

• Source: Discover Nano; 11/23/2024, Vol. 19 Issue 1, p1-17, 17p

Record details

Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy.

• Authors : Yao, Haochen; Ma, Sheng; Huang, Juanjuan

Subjects: CYTOTOXIC T cells; KILLER cells; GUT microbiome

• Source: Advanced Science; Nov2024, Vol. 11 Issue 44, p1-14, 14p

Record details

Unveiling new chapters in medullary thyroid carcinoma therapy: advances in molecular genetics and targeted treatment strategies.

• Authors : Jia-Xuan Huai; Fang Wang; Wen-Hui Zhang

Subjects: MEDULLARY thyroid carcinoma; MOLECULAR genetics; THYROID cancer

• Source: Frontiers in Endocrinology; 2024, p1-7, 7p

Record details

Polymeric nanoparticles loaded with vincristine and carbon dots for hepatocellular carcinoma therapy and imaging.

• Authors : Fawaz, Walaa; Hanano, Abdulsamie; Murad, Hossam

Subjects: BIODEGRADABLE nanoparticles; LIVER cancer; COLLOIDAL stability

• Source: Scientific Reports; 10/18/2024, Vol. 14 Issue 1, p1-12, 12p

Record details

Ferroptosis: a new promising target for hepatocellular carcinoma therapy.

• Authors : Xu, Qiaoping; Ren, Lanqi; Ren, Ning

• Source: Molecular & Cellular Biochemistry; Oct2024, Vol. 479 Issue 10, p2615-2636, 22p

Record details

Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy.

• Authors : Forman, Rebecca; Long, Jessica B; Westvold, Sarah J

Subjects: MEDICAL care costs; MEDICARE costs; PATIENTS' attitudes

• Source: JNCI Cancer Spectrum; Oct2024, Vol. 8 Issue 5, p1-8, 8p

Record details

Ultrasmall Enzyodynamic PANoptosis Nano‐Inducers for Ultrasound‐Amplified Hepatocellular Carcinoma Therapy and Lung Metastasis Inhibition.

• Authors : Wei, Wuyang; Wang, Hai; Ren, Chunrong

• Source: Advanced Materials; Nov2024, Vol. 36 Issue 45, p1-15, 15p

Record details

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy.

• Authors : Beibei Liu; Ling Liu; Yang Liu

Subjects: DRUG resistance in cancer cells; CELL survival; NON-coding RNA

• Source: Frontiers in Immunology; 2024, p1-28, 28p

Record details

Immunoproteasome acted as immunotherapy 'coffee companion' in advanced carcinoma therapy.

• Authors : Shaoyan Shi; Xuehai Ou; Chao Liu

Subjects: IMMUNE checkpoint inhibitors; ANTIGEN presentation; IMMUNOREGULATION

• Source: Frontiers in Immunology; 2024, p1-9, 9p

Record details

Sweet dreams could be made of this: carbohydrate‐responsive element‐binding protein (ChREBP) as a target for hepatocellular carcinoma therapy.

• Authors : Fernández‐Barrena, Maite G.; Avila, Matías A.

• Source: Molecular Oncology; Sep2024, Vol. 18 Issue 9, p2107-2110, 4p

Record details